BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 33560403)

  • 1. Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets.
    Stratmann S; Yones SA; Mayrhofer M; Norgren N; Skaftason A; Sun J; Smolinska K; Komorowski J; Herlin MK; Sundström C; Eriksson A; Höglund M; Palle J; Abrahamsson J; Jahnukainen K; Munthe-Kaas MC; Zeller B; Tamm KP; Cavelier L; Holmfeldt L
    Blood Adv; 2021 Feb; 5(3):900-912. PubMed ID: 33560403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-Generation Sequencing-Based Genomic Profiling of Children with Acute Myeloid Leukemia.
    Krizsán S; Péterffy B; Egyed B; Nagy T; Sebestyén E; Hegyi LL; Jakab Z; Erdélyi DJ; Müller J; Péter G; Csanádi K; Kállay K; Kriván G; Barna G; Bedics G; Haltrich I; Ottóffy G; Csernus K; Vojcek Á; Tiszlavicz LG; Gábor KM; Kelemen Á; Hauser P; Gaál Z; Szegedi I; Ujfalusi A; Kajtár B; Kiss C; Matolcsy A; Tímár B; Kovács G; Alpár D; Bödör C
    J Mol Diagn; 2023 Aug; 25(8):555-568. PubMed ID: 37088137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Genomic Analysis Identifies UBTF Tandem Duplications as a Recurrent Lesion in Pediatric Acute Myeloid Leukemia.
    Umeda M; Ma J; Huang BJ; Hagiwara K; Westover T; Abdelhamed S; Barajas JM; Thomas ME; Walsh MP; Song G; Tian L; Liu Y; Chen X; Kolekar P; Tran Q; Foy SG; Maciaszek JL; Kleist AB; Leonti AR; Ju B; Easton J; Wu H; Valentine V; Valentine MB; Liu YC; Ries RE; Smith JL; Parganas E; Iacobucci I; Hiltenbrand R; Miller J; Myers JR; Rampersaud E; Rahbarinia D; Rusch M; Wu G; Inaba H; Wang YC; Alonzo TA; Downing JR; Mullighan CG; Pounds S; Babu MM; Zhang J; Rubnitz JE; Meshinchi S; Ma X; Klco JM
    Blood Cancer Discov; 2022 May; 3(3):194-207. PubMed ID: 35176137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Profiling of Pediatric Acute Myeloid Leukemia Reveals a Changing Mutational Landscape from Disease Diagnosis to Relapse.
    Farrar JE; Schuback HL; Ries RE; Wai D; Hampton OA; Trevino LR; Alonzo TA; Guidry Auvil JM; Davidsen TM; Gesuwan P; Hermida L; Muzny DM; Dewal N; Rustagi N; Lewis LR; Gamis AS; Wheeler DA; Smith MA; Gerhard DS; Meshinchi S
    Cancer Res; 2016 Apr; 76(8):2197-205. PubMed ID: 26941285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing.
    Masetti R; Castelli I; Astolfi A; Bertuccio SN; Indio V; Togni M; Belotti T; Serravalle S; Tarantino G; Zecca M; Pigazzi M; Basso G; Pession A; Locatelli F
    Oncotarget; 2016 Aug; 7(35):56746-56757. PubMed ID: 27462774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse.
    Garg M; Nagata Y; Kanojia D; Mayakonda A; Yoshida K; Haridas Keloth S; Zang ZJ; Okuno Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ding LW; Alpermann T; Sun QY; Lin DC; Chien W; Madan V; Liu LZ; Tan KT; Sampath A; Venkatesan S; Inokuchi K; Wakita S; Yamaguchi H; Chng WJ; Kham SK; Yeoh AE; Sanada M; Schiller J; Kreuzer KA; Kornblau SM; Kantarjian HM; Haferlach T; Lill M; Kuo MC; Shih LY; Blau IW; Blau O; Yang H; Ogawa S; Koeffler HP
    Blood; 2015 Nov; 126(22):2491-501. PubMed ID: 26438511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression.
    Stratmann S; Yones SA; Garbulowski M; Sun J; Skaftason A; Mayrhofer M; Norgren N; Herlin MK; Sundström C; Eriksson A; Höglund M; Palle J; Abrahamsson J; Jahnukainen K; Munthe-Kaas MC; Zeller B; Tamm KP; Cavelier L; Komorowski J; Holmfeldt L
    Blood Adv; 2022 Jan; 6(1):152-164. PubMed ID: 34619772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicine.
    Bachas C; Schuurhuis GJ; Hollink IH; Kwidama ZJ; Goemans BF; Zwaan CM; van den Heuvel-Eibrink MM; de Bont ES; Reinhardt D; Creutzig U; de Haas V; Assaraf YG; Kaspers GJ; Cloos J
    Blood; 2010 Oct; 116(15):2752-8. PubMed ID: 20592250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia.
    Shiba N; Yoshida K; Shiraishi Y; Okuno Y; Yamato G; Hara Y; Nagata Y; Chiba K; Tanaka H; Terui K; Kato M; Park MJ; Ohki K; Shimada A; Takita J; Tomizawa D; Kudo K; Arakawa H; Adachi S; Taga T; Tawa A; Ito E; Horibe K; Sanada M; Miyano S; Ogawa S; Hayashi Y
    Br J Haematol; 2016 Nov; 175(3):476-489. PubMed ID: 27470916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole exome sequencing identifies novel mutations of epigenetic regulators in chemorefractory pediatric acute myeloid leukemia.
    Zhan D; Zhang Y; Xiao P; Zheng X; Ruan M; Zhang J; Chen A; Zou Y; Chen Y; Huang G; Hu S; Wang QF; Zhu X
    Leuk Res; 2018 Feb; 65():20-24. PubMed ID: 29253671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent
    Matsuo H; Yoshida K; Fukumura K; Nakatani K; Noguchi Y; Takasaki S; Noura M; Shiozawa Y; Shiraishi Y; Chiba K; Tanaka H; Okada A; Nannya Y; Takeda J; Ueno H; Shiba N; Yamato G; Handa H; Ono Y; Hiramoto N; Ishikawa T; Usuki K; Ishiyama K; Miyawaki S; Itonaga H; Miyazaki Y; Kawamura M; Yamaguchi H; Kiyokawa N; Tomizawa D; Taga T; Tawa A; Hayashi Y; Mano H; Miyano S; Kamikubo Y; Ogawa S; Adachi S
    Blood Adv; 2018 Nov; 2(21):2879-2889. PubMed ID: 30381403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual tumor response testing in multiple relapsed acute myeloid leukemia in children.
    Styczynski J; Piatkowska M; Czyzewski K; Pogorzala M; Wysocki M
    Anticancer Res; 2013 Mar; 33(3):1189-93. PubMed ID: 23482801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapse.
    Wang ES; Sait SN; Gold D; Mashtare T; Starostik P; Ford LA; Wetzler M; Nowak NJ; Deeb G
    Cancer Genet Cytogenet; 2010 Oct; 202(2):101-7. PubMed ID: 20875872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.
    Ding L; Ley TJ; Larson DE; Miller CA; Koboldt DC; Welch JS; Ritchey JK; Young MA; Lamprecht T; McLellan MD; McMichael JF; Wallis JW; Lu C; Shen D; Harris CC; Dooling DJ; Fulton RS; Fulton LL; Chen K; Schmidt H; Kalicki-Veizer J; Magrini VJ; Cook L; McGrath SD; Vickery TL; Wendl MC; Heath S; Watson MA; Link DC; Tomasson MH; Shannon WD; Payton JE; Kulkarni S; Westervelt P; Walter MJ; Graubert TA; Mardis ER; Wilson RK; DiPersio JF
    Nature; 2012 Jan; 481(7382):506-10. PubMed ID: 22237025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
    Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
    Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia.
    Verboon LJ; Obulkasim A; de Rooij JD; Katsman-Kuipers JE; Sonneveld E; Baruchel A; Trka J; Reinhardt D; Pieters R; Cloos J; Kaspers GJ; Klusmann JH; Zwaan CM; Fornerod M; van den Heuvel-Eibrink MM
    Oncotarget; 2016 Jul; 7(30):48412-48422. PubMed ID: 27351222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperating mutations of receptor tyrosine kinases and Ras genes in childhood core-binding factor acute myeloid leukemia and a comparative analysis on paired diagnosis and relapse samples.
    Shih LY; Liang DC; Huang CF; Chang YT; Lai CL; Lin TH; Yang CP; Hung IJ; Liu HC; Jaing TH; Wang LY; Yeh TC
    Leukemia; 2008 Feb; 22(2):303-7. PubMed ID: 17960171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia.
    McNeer NA; Philip J; Geiger H; Ries RE; Lavallée VP; Walsh M; Shah M; Arora K; Emde AK; Robine N; Alonzo TA; Kolb EA; Gamis AS; Smith M; Gerhard DS; Guidry-Auvil J; Meshinchi S; Kentsis A
    Leukemia; 2019 Aug; 33(8):1934-1943. PubMed ID: 30760869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05R study.
    Moritake H; Tanaka S; Miyamura T; Nakayama H; Shiba N; Shimada A; Terui K; Yuza Y; Koh K; Goto H; Kakuda H; Saito A; Hasegawa D; Iwamoto S; Taga T; Adachi S; Tomizawa D
    Pediatr Blood Cancer; 2021 Jan; 68(1):e28736. PubMed ID: 32991072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML.
    Schnittger S; Kinkelin U; Schoch C; Heinecke A; Haase D; Haferlach T; Büchner T; Wörmann B; Hiddemann W; Griesinger F
    Leukemia; 2000 May; 14(5):796-804. PubMed ID: 10803509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.